Home » Topics » Regulatory

Regulatory
RSS

Ajinomoto and Dainippon granted approval for additional indication for Niflec and Gasmotin

April 27, 2009

European Commission approves Removab for malignant ascites

April 24, 2009

Simponi approved for RA, psoriatic arthritis and ankylosing spondylitis

April 14, 2009

FDA approves Afinitor in patients with advanced kidney cancer

March 31, 2009

Additional indication for Actos approved in Japan

March 26, 2009

Fablyn approved in Europe for the treatment of osteoporosis

March 26, 2009

FDA approves Symbyax for treatment-resistant depression

March 24, 2009

Dainippon launches Trerief in Japan for Parkinson's disease

March 16, 2009

FDA approves expanded indication for peginterferon-based combination therapy

March 13, 2009

Mepact receives E.U. approval for non-metastatic resectable osteosarcoma

March 11, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...